Martin G. Pomper

Diffusion tensor MR imaging of the brain and white matter tractography.

Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma.

Brain white matter anatomy of tumor patients evaluated with diffusion tensor imaging.

Quantitative MR spectroscopic imaging of brain lesions in patients with AIDS: correlation with [11C-methyl]thymidine PET and thallium-201 SPECT.

Can small animal imaging accelerate drug development?

Tissue sodium concentration in human brain tumors as measured with 23Na MR imaging.

The surgical bed after BCNU polymer wafer placement for recurrent glioma: serial assessment on CT and MR imaging.

11C-MCG: synthesis, uptake selectivity, and primate PET of a probe for glutamate carboxypeptidase II (NAALADase).

Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria.

Predicting the success of a radiopharmaceutical for in vivo imaging of central nervous system neuroreceptor systems.

PET imaging of GRP receptor expression in prostate cancer.

Metabolites in ventricular cerebrospinal fluid detected by proton magnetic resonance spectroscopic imaging.

Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP.

Positron emission tomography in molecular imaging. Could the promise of personalized patient care be reaching fruition?

Autoimmune hypophysitis.

Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.

Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.

A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia.

Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer.

Glutamate carboxypeptidase II levels in rodent brain using [125I]DCIT quantitative autoradiography.

Quantitative proton magnetic resonance spectroscopic imaging: regional variations in the corpus callosum and cortical gray matter.

Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS.

Synthesis and biodistribution of (11)C-GW7845, a positron-emitting agonist for peroxisome proliferator-activated receptor-{gamma}.

Small animal imaging in drug development.

In vivo imaging of peripheral benzodiazepine receptors in mouse lungs: a biomarker of inflammation.

Characteristic MR imaging changes in severe hypermethioninemic states.

NAAG peptidase inhibitors and their potential for diagnosis and therapy.

Translational molecular imaging for cancer.

Proton MR spectroscopy in hyperhomocysteinemia with elevated blood methionine levels.

Amide proton transfer imaging of human brain tumors at 3T.

Performance evaluation of the GE healthcare eXplore VISTA dual-ring small-animal PET scanner.

Virus-associated tumor imaging by induction of viral gene expression.

Potential clinical role of FDG-PET in detecting sarcomatous transformation in von Recklinghausen's disease.

FDG-PET for pharmacodynamic assessment of the fatty acid synthase inhibitor C75 in an experimental model of lung cancer.

Radiolabeled anti-claudin 4 and anti-prostate stem cell antigen: initial imaging in experimental models of pancreatic cancer.

In vivo differentiation of N-acetyl aspartyl glutamate from N-acetyl aspartate at 3 Tesla.

Workshop on imaging science development for cancer prevention and preemption.

New techniques for imaging Human Immunodeficiency Virus associated cognitive impairment in the era of highly active antiretroviral therapy.

Molecular neuroimaging: from conventional to emerging techniques.

ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging.

Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT.

Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches.

Dysregulation of glutamate carboxypeptidase II in psychiatric disease.

Targeted molecular imaging in oncology: focus on radiation therapy.

N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.

Molecular imaging: the future of modern medicine.

Molecular imaging of metastatic potential.

Spatio-temporal modification of collagen scaffolds mediated by triple helical propensity.

Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).

Characterization of a targeted nanoparticle functionalized with a urea-based inhibitor of prostate-specific membrane antigen (PSMA).

Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors.

Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging.

An immunotolerant HER-2/neu transgenic mouse model of metastatic breast cancer.

Imaging virus-associated cancer.

Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization.

Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer.

Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp.

Serial imaging of human embryonic stem-cell engraftment and teratoma formation in live mouse models.

Detection of dose response in chronic doxorubicin-mediated cell death with cardiac technetium 99m annexin V single-photon emission computed tomography.

[18F]fluorodeoxyglucose positron emission tomography correlates with Akt pathway activity but is not predictive of clinical outcome during mTOR inhibitor therapy.

Pharmacodynamic markers for choline kinase down-regulation in breast cancer cells.

Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT.

Optimization of peptide-based inhibitors of prostate-specific antigen (PSA) as targeted imaging agents for prostate cancer.

Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.

EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts.

Bacterial thymidine kinase as a non-invasive imaging reporter for Mycobacterium tuberculosis in live animals.

Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans.

Letter to the editor.

New agents and techniques for imaging prostate cancer.

Synthesis of [(125)I]iodoDPA-713: a new probe for imaging inflammation.

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment.

A low molecular weight PSMA-based fluorescent imaging agent for cancer.

Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery.

Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV.

Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies.

Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.

Positron emission tomography for serial imaging of the contused adult rat spinal cord.

Preclinical evaluation of an 131I-labeled benzamide for targeted radiotherapy of metastatic melanoma.

Molecular imaging of CXCR4 receptor expression in human cancer xenografts with [64Cu]AMD3100 positron emission tomography.

68Ga-labeled inhibitors of prostate-specific membrane antigen (PSMA) for imaging prostate cancer.

Brain metabolism and cognitive impairment in HIV infection: a 3-T magnetic resonance spectroscopy study.

Improved Syntheses of Precursors for PET Radioligands [F]XTRA and [F]AZAN.

Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection.

Magnetic resonance imaging features of pituicytomas: analysis of 10 cases.

Experimental evaluation of depth-of-interaction correction in a small-animal positron emission tomography scanner.

Effect of nitroxoline on angiogenesis and growth of human bladder cancer.

Continuing education course #1: non-invasive imaging as a problem-solving tool and translational biomarker strategy in toxicologic pathology.

Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression.

The evolution of imaging in cancer: current state and future challenges.

A robust approach to enhance tumor-selective accumulation of nanoparticles.

High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S).

Reference tissue modeling with parameter coupling: application to a study of SERT binding in HIV.

Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and radioiodide.

Imaging CXCR4 expression in human cancer xenografts: evaluation of monocyclam 64Cu-AMD3465.

Strong inhibition of xenografted tumor growth by low-level doses of [(32)P]ATP.

A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.

Mechanisms of dendritic cell trafficking across the blood-brain barrier.

Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen.

CuInSe/ZnS core/shell NIR quantum dots for biomedical imaging.

Metabolic signatures imaged in cancer-induced cachexia.

2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.

Decreased microglial activation in MS patients treated with glatiramer acetate.

Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.

A modular strategy to prepare multivalent inhibitors of prostate-specific membrane antigen (PSMA).

Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans.

Cancer imaging: Gene transcription-based imaging and therapeutic systems.

[32P]ATP inhibits the growth of xenografted tumors in nude mice.

Diagnostic accuracy using diffusion tensor imaging in the diagnosis of ALS: a meta-analysis.

Development of a high-throughput fluorescence polarization assay to identify novel ligands of glutamate carboxypeptidase II.

Ovarian cancer gene therapy using HPV-16 pseudovirion carrying the HSV-tk gene.

PSMA-targeted theranostic nanoplex for prostate cancer therapy.

Targeting collagen strands by photo-triggered triple-helix hybridization.

Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules.

Hypoxia regulates CD44 and its variant isoforms through HIF-1α in triple negative breast cancer.

Theranostic imaging of cancer.

Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms.

Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood-brain barrier through paracellular transmigration and ERK activation.

[(125)I]FIAU imaging in a preclinical model of lung infection: quantification of bacterial load.

Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen.

Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.

Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.

Transforming thymidine into a magnetic resonance imaging probe for monitoring gene expression.

Subcortical dopaminergic deficits in a DISC1 mutant model: a study in direct reference to human molecular brain imaging.

Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement.

Clinical applications of Gallium-68.

Molecular imaging of conscious, unrestrained mice with AwakeSPECT.

Student award winner in the Ph.D. category for the 2013 society for biomaterials annual meeting and exposition, april 10-13, 2013, Boston, Massachusetts : biomaterial-mediated cancer-specific DNA delivery to liver cell cultures using synthetic poly(beta-amino ester)s.

PET imaging in prostate cancer: focus on prostate-specific membrane antigen.

Radiochemical synthesis and in vivo evaluation of [18F]AZ11637326: an agonist probe for the α7 nicotinic acetylcholine receptor.

Mix to validate: a facile, reversible PEGylation for fast screening of potential therapeutic proteins in vivo.

Salicylic Acid and Analogues as diaCEST MRI Contrast Agents with Highly Shifted Exchangeable Proton Frequencies.

An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy.

Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA).

Noninvasive molecular imaging of tuberculosis-associated inflammation with radioiodinated DPA-713.

Diagnostic accuracy of diffusion tensor imaging in amyotrophic lateral sclerosis: a systematic review and individual patient data meta-analysis.

Detection and localization of carcinoma within the prostate using high resolution transrectal gamma imaging (TRGI) of monoclonal antibody directed at prostate specific membrane antigen (PSMA)--proof of concept and initial imaging results.

Translational Molecular Imaging of Prostate Cancer.

Imaging Axl expression in pancreatic and prostate cancer xenografts.

Sex Differences in Translocator Protein 18 kDa (TSPO) in the Heart: Implications for Imaging Myocardial Inflammation.

Heterobivalent Agents Targeting PSMA and Integrin-αvβ3.